Evidence map›Paper›PMID 29503800›Full record

ArticleOsong public health and research perspectives2018

Prevalence of Fecal Carriage of CTX-M-15 Beta-Lactamase-Producing

María Araque, Indira Labrador

Open access · diamondAbstract read
In one paragraph

Article in Osong public health and research perspectives, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Genomic Diversity and Extended-SpectrumInternational journal of microbiology · 2026
    Article
  4. Co-Harboring of Beta-Lactamases andAntibiotics (Basel, Switzerland) · 2023
    Article
  5. First Report of IMI-2-ProducingAntibiotics (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Extended-Spectrum Beta-Lactamases ProducingInfection and drug resistance · 2022
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

María AraqueLaboratory of Molecular Microbiology, Department of Microbiology and Parasitology, University of The Andes, Mérida, Venezuela.
Indira LabradorLaboratory of Molecular Microbiology, Department of Microbiology and Parasitology, University of The Andes, Mérida, Venezuela.
University of the Andes · VE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAntimicrobial resistant extended-spectrum-β-lactamase-producing

methodsA total of 78 fecal samples were collected in healthy children aged from 1 to 5 years. ESBL-EC were selected in MacConkey agar plates with cefotaxime and further confirmed by the VITEK 2 system. ESBL were phenotypically detected and presence of

resultsOf the 78 children studied, 27 (34.6%) carried ESBL-EC. All strains harbored the

conclusionThis is the first study describing the high prevalence of fecal carriage of ESBL-EC expressing CTX-M-15- among very young, healthy children from a rural Andean village in Venezuela with scarce antibiotic exposure, underlining the importance of this population as a reservoir.

Indexed as

CTX-M-15EnterobacteriaceaeExtended-spectrum-β-lactamasesfecal carriagehealthy childrenVenezuela

Identifiers

PMID29503800
PMCPMC5831685
OpenAlexW2789263964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.